… the generation of monoclonal antibodies (mAbs) by Köhler and … In this Review, we first
provide an overview of the … Most therapeutic mAbs in clinical use or development against …

… review, we summarized recent studies on the therapeutic effects and clinical trial results of
these mabs … impact of aducanumab and lecanemab on AD pathology and clinical profiles. The …

… therapeutics for other infectious diseases. Here, we provide an overview of SARS-CoV-2-neutralizing
mAbs, including their … the clinical trials of approved or late-stage mAb therapeutics. …

… This review discusses the advantages and challenges associated with monoclonal
antibody … rights to a wide range of monoclonal antibodies for therapeutic application. These …

… Drug delivery systems (DDS) can be optimized for clinical applications by controlling these
… monoclonal antibody for generating novel nanomedicines for breast cancer therapy by far. …

… the antibody is linked to the payload are key determinants of the safety and efficacy of ADCs.
This review provides an overview … At present, four ADCs are in clinical use approved by the …

… In this review, we mainly discuss previous and current … in technical development and their
clinical applications. … BsAb bispecific antibody, Mab monoclonal antibody, BiTE bispecific T-cell …

… This review provides the current status of the development of … into clinical use for prophylactic
and therapeutic purposes … can be identified, and therapeutic monoclonal antibody can be …

… Summary Human monoclonal antibodies are safe, preventive, and therapeutic tools that
can be rapidly developed to help restore the massive health and economic disruption caused …

… the superior targeting specificity of monoclonal antibody (mAb) and … strategies and their
preclinical and clinical applications. We also … In the last part of the review, we discuss practical …